TGFB1 and Interstitial cardiac fibrosis: More importantly, renalase treatment significantly alleviates cardiac interstitial fibrosis, followed by the increased cardiac expression of MMP-1, lower expression of TIMP-1, and TGF-β, and decreased phosphorylated ERK 1/2 levels.